An interdisciplinary team of Northwestern Medicine investigators led by Karen Ridge, PhD, has been awarded a $14 million grant from the National Heart, Lung, and Blood Institute to study the mechanisms that promote lung tissue repair in patients with severe viral pneumonia.
The damaging effects of toxic proteins created in one inherited form of amyotrophic lateral sclerosis (ALS) are mediated by an enzyme called SPOP.
The ability to learn novel physical movements, similar to those taught in rehabilitation for people with stroke, can be improved by reactivating specific memories of the new task during sleep, according to a new study.
A new Northwestern Medicine study published in Nature explains why dopamine neurons are lost in Parkinson’s disease, and demonstrated that a gene therapy targeting the brain’s substantia nigra can substantially boost the benefits of levodopa, an important medication for treating the disease.
A new drug improved management of ulcerative colitis, according to a study published in NEJM.
Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection.
Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, which may facilitate the construction of synthetic protein materials.
Through the Robert J. Havey, MD Institute for Global Health, Feinberg faculty across disciplines are training investigators from Africa, many of whom are enrolled in Feinberg graduate programs, on how to effectively conduct research about diseases currently impacting their home countries.
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
A newly discovered cause of balding in aging male mice could reveal a cause of hair loss in men and women as well, reports a study from Northwestern Medicine scientists.